• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病中的肠道纤维化——现有知识和未来展望。

Intestinal fibrosis in inflammatory bowel disease - Current knowledge and future perspectives.

机构信息

Department of Internal Medicine I, University of Regensburg, Regensburg, Germany; Department of Gastroenterology and Hepatology, Cleveland Clinic Foundation, Cleveland, USA; Department of Pathobiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, USA.

出版信息

J Crohns Colitis. 2008 Dec;2(4):279-90. doi: 10.1016/j.crohns.2008.05.009. Epub 2008 Jul 3.

DOI:10.1016/j.crohns.2008.05.009
PMID:21172225
Abstract

BACKGROUND AND AIMS

Intestinal fibrosis is a common complication of IBD that can become seriously symptomatic and may require surgical intervention if stricture formation ensues. This review discusses existing and developing knowledge of intestinal fibrosis and its implications for therapy.

METHODS

Review of the literature, personal communications, unpublished observations.

RESULTS

Known mechanisms of intestinal fibrosis include fibroblast proliferation and migration, activation of stellate cells, and extraintestinal fibroblast recruitment. However, novel mechanisms are being uncovered, including epithelial-to-mesenchymal transition, endothelial-to-mesenchymal transition, pericyte differentiation, and fibrocyte recruitment. Most of the traditional and novel mechanisms underlying intestinal fibrosis are associated to the presence of chronic inflammation, but is also possible that fibrosis develops independently of persistent immune activation in the gut. At the moment, the development of preventive, non-interventional, and more effective management of intestinal fibrosis is hampered by the lack of a greater knowledge of its basic pathophysiology and predisposing factors.

CONCLUSIONS

It is reasonable to expect that therapy of IBD-associated fibrosis will radically improve once the underlying mechanisms are better understood, and therapeutic modalities will emerge that prevent or reverse this complication of IBD.

摘要

背景与目的

肠纤维化是 IBD 的常见并发症,如果发生狭窄,可能会出现严重症状,并可能需要手术干预。本文讨论了肠纤维化的现有和发展中的知识及其对治疗的影响。

方法

文献复习、个人交流、未发表的观察结果。

结果

已知的肠纤维化机制包括成纤维细胞增殖和迁移、星状细胞激活以及肠外成纤维细胞募集。然而,新的机制正在被揭示,包括上皮细胞-间充质转化、内皮细胞-间充质转化、周细胞分化和成纤维细胞募集。肠纤维化的大多数传统和新机制都与慢性炎症的存在有关,但纤维化也可能在肠道持续免疫激活之外独立发展。目前,由于对其基本病理生理学和易患因素缺乏更多了解,预防、非干预性和更有效的肠纤维化管理的发展受到阻碍。

结论

一旦更好地了解潜在机制,预计 IBD 相关纤维化的治疗将得到极大改善,并且将出现预防或逆转这种 IBD 并发症的治疗方法。

相似文献

1
Intestinal fibrosis in inflammatory bowel disease - Current knowledge and future perspectives.炎症性肠病中的肠道纤维化——现有知识和未来展望。
J Crohns Colitis. 2008 Dec;2(4):279-90. doi: 10.1016/j.crohns.2008.05.009. Epub 2008 Jul 3.
2
Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science.炎症性肠病中的肠道纤维化:基础与临床科学进展
Curr Opin Gastroenterol. 2008 Jul;24(4):462-8. doi: 10.1097/MOG.0b013e3282ff8b36.
3
Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Disease and Perspectives for Therapeutic Implication.炎症性肠病中肠道纤维化的发病机制及治疗意义展望
Dig Dis. 2017;35(1-2):25-31. doi: 10.1159/000449079. Epub 2017 Feb 1.
4
Mechanisms and models for intestinal fibrosis in IBD.炎症性肠病中肠道纤维化的机制与模型
Dig Dis. 2014;32 Suppl 1:26-34. doi: 10.1159/000367822. Epub 2014 Dec 17.
5
Can we prevent, reduce or reverse intestinal fibrosis in IBD?我们能否预防、减轻或逆转 IBD 中的肠道纤维化?
Eur Rev Med Pharmacol Sci. 2013 May;17(10):1283-304.
6
The Molecular Mechanism of Transforming Growth Factor-β Signaling for Intestinal Fibrosis: A Mini-Review.转化生长因子-β信号通路介导肠道纤维化的分子机制:一篇综述短文
Front Pharmacol. 2019 Feb 27;10:162. doi: 10.3389/fphar.2019.00162. eCollection 2019.
7
Role of non-inflammatory factors in intestinal fibrosis.非炎症因素在肠道纤维化中的作用。
J Dig Dis. 2020 Jun;21(6):315-318. doi: 10.1111/1751-2980.12883.
8
Mechanisms of initiation and progression of intestinal fibrosis in IBD.炎症性肠病中肠道纤维化的起始和进展机制
Scand J Gastroenterol. 2015 Jan;50(1):53-65. doi: 10.3109/00365521.2014.968863.
9
Inflammation accelerating intestinal fibrosis: from mechanism to clinic.炎症促进肠道纤维化:从机制到临床。
Eur J Med Res. 2024 Jun 18;29(1):335. doi: 10.1186/s40001-024-01932-2.
10
Features of intestinal lesions in the clinical course of inflammatory bowel diseases.炎症性肠病临床病程中肠道病变的特征
Ital J Anat Embryol. 2014;119(3):286-303.

引用本文的文献

1
Explainable deep learning for stratified medicine in inflammatory bowel disease.用于炎症性肠病分层医学的可解释深度学习
Genome Biol. 2025 Jul 24;26(1):223. doi: 10.1186/s13059-025-03692-6.
2
SAR Consensus Recommendations for Defining Small Bowel Crohn Disease Strictures at CT and MR Enterography.CT和MR小肠造影中定义小肠克罗恩病狭窄的SAR共识建议。
Radiology. 2025 Jul;316(1):e243123. doi: 10.1148/radiol.243123.
3
Inflammatory Bowel Disease and Stroke: Exploring Hidden Vascular Risks.炎症性肠病与中风:探寻潜在的血管风险
Cureus. 2025 Feb 19;17(2):e79304. doi: 10.7759/cureus.79304. eCollection 2025 Feb.
4
Intestinal fibrosis associated with inflammatory bowel disease: Known and unknown.与炎症性肠病相关的肠道纤维化:已知与未知
Chin Med J (Engl). 2025 Apr 20;138(8):883-893. doi: 10.1097/CM9.0000000000003545. Epub 2025 Feb 27.
5
Identification of Angiogenesis-Related Gene Signatures and Prediction of Potential Therapeutic Targets in Ulcerative Colitis Using Integrated Bioinformatics.运用综合生物信息学鉴定溃疡性结肠炎中血管生成相关基因特征并预测潜在治疗靶点
J Inflamm Res. 2024 Dec 27;17:11699-11717. doi: 10.2147/JIR.S478880. eCollection 2024.
6
Phytochemical Compounds as Promising Therapeutics for Intestinal Fibrosis in Inflammatory Bowel Disease: A Critical Review.植物化学物质作为炎症性肠病中肠纤维化的有前途的治疗方法:批判性评价。
Nutrients. 2024 Oct 25;16(21):3633. doi: 10.3390/nu16213633.
7
Inflammatory Bowel Disease: Immune Function, Tissue Fibrosis and Current Therapies.炎症性肠病:免疫功能、组织纤维化和当前治疗方法。
Int J Mol Sci. 2024 Jun 11;25(12):6416. doi: 10.3390/ijms25126416.
8
Role of pH-sensing receptors in colitis.酸感应受体在结肠炎中的作用。
Pflugers Arch. 2024 Apr;476(4):611-622. doi: 10.1007/s00424-024-02943-y. Epub 2024 Mar 22.
9
Current Approach to Risk Factors and Biomarkers of Intestinal Fibrosis in Inflammatory Bowel Disease.当前炎症性肠病中肠道纤维化的危险因素和生物标志物的处理方法。
Medicina (Kaunas). 2024 Feb 10;60(2):305. doi: 10.3390/medicina60020305.
10
Fractal analysis of extracellular matrix for observer-independent quantification of intestinal fibrosis in Crohn's disease.基于分形分析的细胞外基质方法可实现克罗恩病肠纤维化的观察者间独立定量评估。
Sci Rep. 2024 Feb 17;14(1):3988. doi: 10.1038/s41598-024-54545-4.